Director, Institute of Lung Health and Immunity (@LungHealthMUC) Researcher @HelmholtzMunich, Immunologist, COPD @Copd_Inet, Soccer fan, opinions are my own!

Munich
Joined June 2013
Why does COPD affect women and men differently? Our latest work in @JCI_insight points to estrogen-driven sphingolipid metabolism as a contributor to airway hyperreactivity and remodeling in COPD, highlighting a potential sex-specific disease mechanism. #CureCOPD #LungResearch 🔗 insight.jci.org/articles/vie…
1
13
41
1,584
The most comprehensive guidance to date on preclinical COPD models is finally out in the ERJ @ERSpublications 🔗 publications.ersnet.org/cont… #COPD #RespiratoryResearch After a tremendous collaborative effort with leading COPD investigators worldwide, this document provides practical recommendations on choosing the best COPD model for each scientific question. We hope it becomes the go-to reference when selecting preclinical COPD models.
1
7
25
1,403
Önder Yildirim retweeted
Does brain aging always mean vessel loss? 🧠We found a surprising hypervascularization, driving cognitive decline & blood-brain barrier damage in aging. 👇🧵biorxiv.org/content/10.64898… Led by @MihailMuc
6
87
4
283
24,925
#WorldCOPDDay “Short of Breath, Think COPD” Helmholtz Munich Drives Research for New Diagnostics, Therapies and Prevention Strategies🫁 👉t1p.de/2sxmc #COPD, the Chronic Obstructive Pulmonary Disease, is a progressive and currently incurable lung disease in which the airways become inflamed and permanently narrowed (obstruction). 💡Worldwide, COPD ranks as the third leading cause of death, with over three million people affected in Germany alone. The challenge: lung damage can occur long before a formal diagnosis is made. Early warning signs like coughing or shortness of breath are often overlooked or underestimated. The World COPD Day 2025 aims to raise awareness of COPD and to highlight the importance of early diagnosis, as the disease is often detected too late. 🌟At #HelmholtzMunich, researchers are driving the development of new diagnostics, therapies, and prevention strategies for COPD. The goal is to understand the immunological foundations of the disease, the impact of nutrition and environmental factors, and how these influences interact with the immune system during the onset and progression of COPD. 👉Check out the Research Highlight “New Hope for Lung Diseases”: t1p.de/lormr @DZG_Forschen @GOLD_COPD @AlionderCPC @LungHealthMUC @StiftungAtemweg #GOLDCOPD2025 #COPDAwareness #LungHealth #ThinkCOPD
3
5
751
Önder Yildirim retweeted
We are introducing LipiGo 🤗 A programmable DNA–lipid nanocarrier 🧬 with built-in targeting logic. It de-targets the liver and redirects mRNA delivery into lymphoid organs, enhancing therapies requiring the immune system. by @cerenkimna @kalorintschi biorxiv.org/content/10.1101/… 1/n
7
77
5
334
32,201
Önder Yildirim retweeted
BREAKING NEWS The Norwegian Nobel Committee has decided to award the 2025 #NobelPeacePrize to Maria Corina Machado for her tireless work promoting democratic rights for the people of Venezuela and for her struggle to achieve a just and peaceful transition from dictatorship to democracy. #NobelPrize
23,929
50,402
16,795
180,337
68,831,931
Önder Yildirim retweeted
Learn what’s new in the 2026 GOLD Report! Highlights include a revised chapter on COPD & multimorbidity, updated guidance on exacerbation management, case-finding, treatment algorithms, and vaccinations. Hear directly from the experts on these key updates! November 12–13 | Philadelphia Marriott Downtown. Register today: bit.ly/3FDHJ99 #GOLDCOPD2025
1
17
24
1,642
At @HelmholtzMunich we are working toward new therapies for #LungDiseases. Our major goal to investigate why COPD develops and progresses, aiming to translate these insights into better treatments. We have founded @copd_inet, where we connect worldwide to advance COPD research.
#WorldLungDay "Healthy Lungs, Healthy Life"🫁 This is the topic of the #WorldLungDay2025. It focuses on practical steps individuals can take and systemic changes needed for better respiratory care. At #HelmholtzMunich, researchers are paving the way for therapies of #LungDiseases. 💡One of the goals is to prevent and treat #COPD. Prof. Önder Yildirim and his team investigate why and how COPD progresses. 👨‍🔬 Önder Yildirim is Director of the Institute of Lung Health and Immunity at #HelmholtzMunich & founder of @copd_inet. 🎥 Watch the video and learn more about how to prevent and treat COPD! @AlionderCPC @copd_inet @LungHealthMUC #COPD2025 #LungHealth #COPDiNet
1
4
201
Treatable traits! New! We compare inflammation, microbiome, rheology and mucins in asthma, COPD, bronchiectasis, CF and controls. Huge overlap in biology but clear neutrophilic and T2 endotypes in all diseases! Endotypes>disease labels @accpchest journal.chestnet.org/article…
2
28
3
80
6,178
The Resilience of the Human Lungs: Evolution, Smoke, and Disease Lung resilience evolved with fire exposure; studying protection in smokers may unlock new COPD therapies amid modern threats @atscommunity 🔓 Open Access 🔗 tinyurl.com/y4b4sh9f
5
13
1,939
Incredible work👇MouseMapper AI sounds like a powerful step forward in systems-level biology. Huge potential for translational insight.. BTW. how does lung 🫁 look like in obesity???
We have developed MouseMapper AI, a deep learning ensemble for the analysis of whole-body systems, including the nervous and immune systems, to map disease/drug perturbations tissue by tissue, organ by organ, at the cellular level in 3D. MouseMapper uncovered obesity-induced whole-neuronal changes, most notably, a loss of trigeminal nerve endings linked to impaired whisker sensitivity, as well as tissue-specific macrophage clustering across the body. Kaltenecker, Horvath, Al-Maskari, Kolabas, Chen… Ertürk, bioRxiv (2024) biorxiv.org/content/10.1101/…
2
1
12
1,569
Önder Yildirim retweeted
The Unagi paper is FINALLY out! We present the first application. of a novel AI tool to human pulmonary fibrosis snRNAseq data to identify cellular trajectories & reversak perturbations with proteomics & PCLS validations!! See 🧵 👇🏼 and paper here nature.com/articles/s41551-0…
1
16
1
57
6,507
The new European Respiratory Journal impact factor is 21. Ranked #2 across all resp journals Thank you to the incredible @donsin4 , all authors, our outstanding editors and journal staff ♥️ @ERSpublications @EuroRespSoc IF for selected respiratory journals below
6
21
4
94
8,930
Wrapping up #ATS2025 with @LungAssociation’s CMO Alberto Rizzo and CEO @HaroldWimmer. Grateful to the @LungAssociation for their support of the @atscommunity and @copd_inet. Let’s keep driving science forward—together. #COPD #cureCOPD Link 🔗 hcplive.com/view/lungcast-at…
2
25
1,535
Önder Yildirim retweeted
📜The European Respiratory Journal is calling for new submissions of original research articles, review papers, research letters & viewpoints for a series on COPD in response to the global challenge the disease poses Learn more & submit online by 30 June: bit.ly/44t7SSE
1
5
3
8
6,774
Agree! This 👇 will be a game changer for the early intervention of COPD. #CureCOPD
A beautiful editorial by the great @FrancyPolverino and @meilan_han on why we need to study the airways of #COPD rather than the blood (which is useless in identifying biomarkers for COPD) bit.ly/3EvEwrX
3
300
Önder Yildirim retweeted
A beautiful editorial by the great @FrancyPolverino and @meilan_han on why we need to study the airways of #COPD rather than the blood (which is useless in identifying biomarkers for COPD) bit.ly/3EvEwrX
22
1
66
4,485